NJ

Naresh Janardan Gaikwad

Active Director Whole-Time Director DIN 02185462
DIN 02185462 First appointment May 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 5 historical roles
Total affiliations 6 Since May 2008
Shareholding value •••• Premium profile

About Naresh Janardan Gaikwad

Data last updated:

Naresh Janardan Gaikwad is a Whole-Time Director at H Jules & Company Ltd (since 2023). The companies operate in Pharma and Chemicals and Materials. H Jules & Company Ltd reported revenue of ₹36.88 Cr (FY 2023). Earlier, Naresh Janardan Gaikwad was a Whole-Time Director at Saif Health Remedies Private Limited (2022–2023) and Director at Hindustan Organic Chemicals Limited (2008–2015) and 3 more.

DIN 02185462
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 16 May 2008
Oldest Company Age 35 yrs
Largest company H Jules & Company Ltd · ₹36.88 Cr (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
H Jules & Company Ltd U24230MH1991PLC062174
Whole-Time Director01 Jul 20231991₹36.88 Cr (FY 2023)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saif Health Remedies Private Limited U55100MH2000PTC126513
Whole-Time Director01 Apr 20222000₹5.57 Cr (FY 2022)Active
Hindustan Organic Chemicals Limited L99999KL1960GOI082753
Director16 May 20081960₹559 Cr (FY 2025)Active
Unijules Life Sciences Limited U52311MH2006PLC158928
Director03 Mar 20102006₹61.64 Cr (FY 2018)Active
Hindustan Fluoro Carbons Ltd L25206TG1983PLC004037
Nominee Director21 Feb 20141983₹2.08 Cr (FY 2024)Active
Zim Laboratories Limited L99999MH1984PLC032172
Director03 Mar 20101984₹385 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Naresh Janardan Gaikwad

NameDINCompanyDesignation
Bhavana08608864H Jules & Company LtdWhole-Time Director
Gajanan Laxmanrao Bangadkar03592469H Jules & Company LtdWhole-Time Director
Himanshuranjan Awadeshchandra Tiwari06448161H Jules & Company LtdDirector
Hussain Rafi10204708H Jules & Company LtdWhole-Time Director

Directorship timeline

Open interactive timeline →
H Jules & Company Ltd
Saif Health Remedies Private Limited
Hindustan Organic Chemicals Limited
Unijules Life Sciences Limited
Premium access

Shareholding and investment profile for Naresh Janardan Gaikwad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Janardan Gaikwad

Naresh Janardan Gaikwad currently holds 1 directorship: H Jules & Company Ltd (Whole-Time Director, since 01 Jul 2023, revenue ₹36.88 Cr (FY 2023)).

Naresh Janardan Gaikwad was first appointed on 16 May 2008 as Director at Hindustan Organic Chemicals Limited. The most recent appointment on record is 01 Jul 2023 at H Jules & Company Ltd.

Naresh Janardan Gaikwad held 5 earlier board appointments: Saif Health Remedies Private Limited (Whole-Time Director, 01 Apr 2022 to 31 Dec 2023); Hindustan Organic Chemicals Limited (Director, 16 May 2008 to 21 May 2015); Unijules Life Sciences Limited (Director, 03 Mar 2010 to 30 Oct 2012); Hindustan Fluoro Carbons Ltd (Nominee Director, 21 Feb 2014 to 03 Sep 2015); Zim Laboratories Limited (Director, 03 Mar 2010 to 01 Apr 2022).

The current boards of Naresh Janardan Gaikwad's companies include Bhavana (H Jules & Company Ltd), Gajanan Laxmanrao Bangadkar (H Jules & Company Ltd), Himanshuranjan Awadeshchandra Tiwari (H Jules & Company Ltd), Hussain Rafi (H Jules & Company Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available